Inovio Biomedical Corp (NASDAQ:INO)

CAPS Rating: 2 out of 5

A biomedical company which deals in developing human applications of electroporation, which uses brief, controlled electrical pulses to increase cellular uptake of a useful biopharmaceuticals.

Recs

0
Player Avatar Jared1048 (< 20) Submitted: 3/20/2014 3:50:38 PM : Outperform Start Price: $15.10 INO Score: -20.71

The product line up that they are going to come out with are second to none! Look into this company and you will soon see its extremely undervalued! checkout there expected earnings in 2017

Featured Broker Partners


Advertisement